Researchers from University of Hyderabad develop nano drug for cancer treatment

Researchers from University of Hyderabad (UoH) have successfully designed and developed a novel and biocompatible polymer based nano drug carriers that can impact immunotherapy and cancer treatment

The team of School of Engineering Sciences have developed it with high potential.

Dr Pradip Paik, associate professor of the School of Engineering Sciences and Technology of the university and his research group developed the polymer based drug carrier.

It is designed in such a way that the capsule  has a hollow poly-N-acryloyl L-phenyl alanine methylester (NAPA-HPN), which has biodegradable nanocapsules of average size ranging from 100-150 nm. The capsules can disperse the drugs for immunity in a way that their effect is sustained with maximum surface charge, thereby increasing their impact.

The group of Researchers said that the NAPA-HPN nanocapsules cannot just handle the infectious and tumor diseases with dexterity but that the capsule can stimulate the immune system as well. Thus capsule could be a path-breaking development in the field of treating immunity and tumour-related diseases. The work has been published as advanced article in the Nanoscale.